SCA
INFI

SAC Capital Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

SAC Capital Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,411,659
Closed -$40.6M – 1131
2014
Q1 		$40.6M Sell
3,411,659
-143,841
-4% -$1.93M 0.21% 121
2013
Q4 		$49.1M Sell
3,555,500
-539,100
-13% -$7.61M 0.29% 91
2013
Q3 		$71.5M Buy
4,094,600
+2,246,657
+122% +$43M 0.39% 60
2013
Q2 		$30M Buy
+1,847,943
New +$57.2M 0.17% 170

Other funds holding INFI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

SAC Capital Advisors's INFI Position: Q2 2014 in Review

SAC Capital Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2014, closing a stake of 3,411,659 shares — an estimated $40.6M sold.

SAC Capital Advisors first reported a position in INFI in Q2 2013 and held it in 4 quarters. The position peaked at $71.5M in Q3 2013. 98 funds tracked by Wall St. Rank hold INFI as of Q2 2014.

  • SAC Capital Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 3,411,659 Infinity Pharmaceuticals, Inc. shares in Q2 2014, an estimated $40.6M.
  • SAC Capital Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
  • SAC Capital Advisors's Infinity Pharmaceuticals, Inc. position peaked at $71.5M in Q3 2013.
  • 98 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.